The correlation among clinicopathological parameters of myocardial damage was investigated in rats administered a single subcutaneous dose of isoproterenol at 0 (saline), 0.04, 0.4 
There is little information available regarding the correlation among these parameters (LDH-1, LDH-2, CK-MB, troponin I and troponin T), and regarding methodological differences. The investigation of such correlation is expected to provide a baseline for interpreting changes in the different parameters with respect to different methods. In addition, different parameters are sometimes employed in toxicity studies, so knowledge regarding such correlation would be valuable information for evaluating the toxicity across toxicity studies (i.e., bridging data between toxicity studies). We have therefore investigated the correlation among clinicopathological parameters of myocardial damage in rats treated with isoproterenol, which is a typical compound for inducing myocardial damage [1, 9] .
The diagnostic significance of clinicopathological parameters [e.g., lactate dehydrogenase (LDH), creatinine kinase (CK), their isoenzymes, and troponin I and T] as markers of myocardial damage has been investigated in rats by several authors. Preus et al. [9] reported the usefulness of LDH-1, LDH-2, and CK-MB, while various other authors reported troponin I and/or troponin T as markers for myocardial damage in rats [1, 2, 4, 5, 8, 12] . Recently, the International Life Science Institute (ILSI) / Health Environmental Science Institute (HESI) have undertaken a comprehensive study focusing on the influence of methodological differences regarding troponin I detection in diluted samples of serum from rats treated with isoproterenol.
Male rats (Crl:CD(SD), SPF) were purchased from Charles River Japan (Shiga, Japan), and used in the experiments when they were 7 weeks old. The rats were housed in individual cages in an animal room under the following conditions: temperature of 23 ± 2°C, relative humidity of 55 ± 15%, 12 air changes per hour and 12-h illumination (7:00 to 19:00). The animals had free access to tap water and to a pelleted commercial laboratory animal feed (CE-2, Clea Japan Inc., Tokyo, Japan). This study was carried out in accordance with the ethical guidelines for the use of experimental animals established by Pfizer Inc.
Based on the results given in previous reports [1, 4] , rats were subcutaneously administered with isoproterenol [(-)-isoproterenol hydrochloride, Sigma (St. Louis, MO)] at a dose of 0 (saline, 5 ml/kg), 0.04, 0.4 or 4 mg/kg (n=3-4 per group). Blood was collected from an abdominal vein into tubes containing heparin or a coagulation accelerator at 4 h after the dosing under anesthesia by isoflurane inhalation. The samples for the assays were obtained by centrifugation: 4,000 × g for 6 min at 4°C for heparinized plasma; 2,000 × g for 15 min at 4°C for serum. After euthanasia by exsanguination, the heart was collected for histopathological examination and analysis of myosin heavy chain gene expression.
Histopathological examination was performed by slides stained with hematoxylin and eosin (HE) or phosphotungstic acid hematoxylin (PTAH). Histopathological changes were classified into 5 grades as follows: negative, minimal, mild, moderate and marked.
The extent of myocardial damage was also examined based on the expression of myocardial remodeling genes of α-, and β-myosin heavy chain (α-MHC and β-MHC) [7, 10, 11] . The mRNAs of α-MHC and β-MHC were quantified by real-time reverse transcription and polymerase chain reaction (RT-PCR) by using an ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA). Total RNA isolated from cardiac tissue was reverse-transcribed using SuperScript II reverse transcriptase (Invitrogen Corp., Carlsbad, CA) and oligo-dT. According to previous reports [6, 7] , the primer sequences employed were as follow: CAG AAA ATG CAC GAT GAG GA (as α-MHC forward); GCA TTC ATA TTT ATT GTG GG (as α-MHC reverse); GGC CTG AAT GAA GAG TAG AT (as β-MHC forward); and GTG TTT CTG CCT AAG GTG CT (as β-MHC reverse). The SYBR Green PCR Master mix (Applied Biosystems) was used for real-time RT-PCR analysis. The value of each sample was calculated by setting the control at one, and further normalized with respect to the value of glyceraldehyde-3-phosphate dehydrogenase.
Total LDH and CK activities in plasma were measured by the UV method using a Hitachi 7070 Automatic Analyzer (Hitachi, Ltd., Tokyo). Their isoenzymes were analyzed with kits for LDH (Titan Gels-LD plate and reagent kit, Helena Laboratories, Beaumont, TX) and CK (Titan III-Lipo cellulose acetate plates and the S-CK reagent kit, Helena Laboratories). The activity of each isoenzyme fraction was calculated by using the total activity and the fraction ratio.
Troponin I in the serum was determined by using 3 methods: chemi-luminescence using a Centaur (Bayer Diagnostics Europe Limited, Dublin, Ireland), chemiluminescence using an Immulyze [Diagnostic Productions Corporation (DPC), Glyn Rhonwy, UK], and a commercially available ELISA kit for rats (Life Diagnostics, West Chester, PA).
Troponin T in heparinized whole blood was measured using Trop T Sensitive, which detects cardiac troponin T by a monoclonal antibody-based immunoassay (Roche Diagnostics, Tokyo) [3] . We modified the method to obtain a semi-quantitative result. By taking the control line of the stick as a reference, a test line was scored as follows: 0 (negative), 1 (trace), 2 (narrow line), 3 (line equal to the control line) and 4 (a line more marked than the control line). This semi-quantitative method was verified by using samples diluted with saline. Table 1 shows the results of the histopathological examination. In all animals treated with isoproterenol, minimal focal myofibrillar degeneration was observed (Fig. 1) . This finding is consistent with previous results on the early myocardial damage induced by isoproterenol [1, 9] . There were no differences in the degree of the change among the dose levels, unlike the results on the clinicopathological parameters described below.
No changes were found in the myocardial remodeling genes α-and β-MHC (Table 2 ). This finding is in agreement with the early-stage myocardial damage observed in the histopathogical examination.
The results of clinicopathological parameters are summarized in Table 3 . The values of all parameters were increased in the groups treated with all doses of isoproterenol, except in the case of total CK activity, which increased only in the high-dose group. Dose-dependent increases were noted in LDH-1, LDH-2, troponin I (Centaur and ELISA) and tropinin T. High sensitivity was demonstrated for LDH-1, LDH-2, CK-MB, troponin I (Centaur), and troponin T, as judged from the statistical probability (P<0.1) and the magnitude of the change between the control and the low dose level. In brief, LDH-1, LDH-2, tropinin I (Centaur) and troponin T showed large magnitudes of change and dose-dependent increases, as well as high sensitivities.
The correlation among parameters for individual data is shown in Table 4 . High correlations were recorded among LDH-1, LDH-2, troponin I (Centaur) and troponin T. As mentioned above, these parameters were those that showed clear dose-responses and large magnitudes of change. We consider these characteristics to have contributed to the high correlation among these parameters.
In the present study, the 3 assay methods for troponin I showed differences in their sensitivities and magnitudes of change. Though the exact reason for this methodological difference is unclear, it might be due to the different antibodies and/or different apparatuses used in the assay systems. At least, the present results suggest that the method used to measure troponin I should be taken into account when this parameter is applied in toxicity studies.
The elimination rates of troponin, LDH-, and CKisoenzymes are known to be different in humans [15] . Thus, in the chronic stage, the correlation among parameters and magnitude of change in each parameter would be expected to differ from the present results. In this study, we found no correlation between the clinicopathological and histopathological results, probably due to the early stage of myocardial damage before the appearance of apparent histopathological changes. Further studies are needed to examine the diagnostic characteristics of the parameters and their correlation with histopathology in a model of chronic-stage myocardial damage. It is generally accepted that LDH-and CK-isoenzymes are not completely specific to myocardial damage [13, 14] . On the other hand, troponin I and T assays have not been fully validated for animals yet. The use of multiple parameters is considered valuable in the evaluation of myocardial toxicity, especially for a compound targeting cardiac tissue. Finally, the correlation among the parameters provides a baseline for interpreting changes in different parameters determined by different methods in toxicity studies. 
